HPS Pharmacies wish to give notice that Sanofi-Aventis is discontinuing CoPlavix® tablets as follows:
Clopidogrel + Aspirin 75mg/100mg
Supplies of CoPlavix® tablets are expected to be exhausted by May 2022. Equivalent brands of clopidogrel + aspirin tablets will remain available.
Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Sanofi-Aventis on 1800 818 806 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates